A detailed history of Tema Etfs LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Tema Etfs LLC holds 10,285 shares of GH stock, worth $970,595. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,285
Previous 11,350 9.38%
Holding current value
$970,595
Previous $591 Million 8.8%
% of portfolio
0.05%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

SELL
$40.98 - $67.42 $43,643 - $71,802
-1,065 Reduced 9.38%
10,285 $643 Million
Q2 2025

Aug 13, 2025

BUY
$37.05 - $52.04 $44,089 - $61,927
1,190 Added 11.71%
11,350 $591 Million
Q1 2025

May 14, 2025

SELL
$31.77 - $49.94 $824,749 - $1.3 Million
-25,960 Reduced 71.87%
10,160 $433 Million
Q4 2024

Feb 14, 2025

BUY
$20.2 - $38.11 $729,624 - $1.38 Million
36,120 New
36,120 $1.1 Billion

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $9.65B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Tema Etfs LLC Portfolio

Follow Tema Etfs LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tema Etfs LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tema Etfs LLC with notifications on news.